View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
Noninvasive ventilation (NIV), which delivers oxygen by a face mask connected to a ventilator, may be more effective at easing dyspnea in patients with end-stage lung cancer than standard oxygen therapy via nasal cannula. In a study-the first to compare the two therapies-92 patients with end-stage lung cancer were randomized to receive either standard oxygen therapy or NIV. Although the 3-month mortality was similar for each group, researchers found that standard oxygen therapy took about 3 hours to become effective, while NIV eased breathing difficulties more quickly. After 3 hours, the therapies were equally effective. In addition, the average use of morphine in the first 24 hours was significantly lower among those on NIV than those on standard oxygen therapy.
Researchers say that NIV not only relieves dyspnea, but it also reduces the work of breathing. As an added benefit, patients need less morphine, reducing opioid-related adverse reactions. The researchers noted that some patients can't tolerate NIV, which requires wearing a face mask, so patients should decide which treatment they prefer.
This study was reported at the American Thoracic Society's 2008 International Conference in Toronto earlier this year.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top